May 2026 Edition
Your RegulatoryID Updates, Now in a Monthly Brief
Starting May 5, RegulatoryID updates move to a single newsletter delivered the first Tuesday of each month. Concise summaries of every U.S. and international transparency obligation on the horizon, with detailed references one click deeper.
Same expert source, now organized into a predictable monthly read. Checkout our preview for May's content below.
About the Newsletter
Each edition draws from RegulatoryID, MedPro's expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead.
What You Receive Each Month
A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions
Concise high-level summaries in the email so you can quickly scan deadlines and what's required
Linked detailed summaries with full regulatory context, deadlines and reference links
Immediate alerts for urgent developments that cannot wait for the next monthly send
Inside the May Edition
Three filing windows opening between May 31 and June 1, spanning U.S. state and international jurisdictions. Subscribe to access the full requirements, source links and submission detail for each.
Nevada Marketing Code of Conduct Annual Filing Form Due 6/1
All wholesalers or manufacturers employing a person to sell or market a drug, medicine, chemical, device, or appliance in Nevada must annually submit the Nevada Marketing Code of Conduct Annual Filing Form. The form is available online. Completed forms must be received by the Nevada State Board of Pharmacy by June 1 at 5 PM PST.
Belgium Sunshine Act Annual Disclosure Due 5/31
Pharmaceutical and medical device companies subject to notification must document and annually publicize the premiums and benefits granted directly and indirectly to Healthcare Professionals, Healthcare Organizations and Patient Organizations by May 31 for the preceding calendar year on the Belgium central platform, betransparent.be. Companies subject to notification must also disclose if they have no reportable transfers of value.
Netherlands Disclosures Due June 1 for Pharmaceutical and Medical Device Companies
License holders and members of the Foundation for the Code of Pharmaceutical Advertising, members of the European Federation of Pharmaceutical Industries and Associations (EFPIA), suppliers of medical devices subject to the Foundation for the Code of Medical Devices and members of MedTech Europe must report transfers of value provided to Dutch HCPs, HCO institutions, associations of HCPs and Patient Organizations.
Subscribe to the RegulatoryID Newsletter
Enter your work email to request access to the full May 2026 edition and to receive ongoing updates direct to your inbox.